Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Terry Maloney who wrote (80597)	5/12/2000 11:50:00 AM
From: Knighty Tin	Read Replies (2) \| Respond to of 132070

Terry, The concern is that Vaso doesn't have the trained staff to teach the technique to all the doctors who need reeducation and to schmooze the masked guys into dropping the surgical knives in their hands. Also, doctors are notably conservative and unwilling to try anything new until their patients or their union force them to do so. So, the fact is, Vaso is going to grow. The question is, will it grow to the Moon, as it should given the efficacy of their therapy? The former should take the stock back to the mid teens. The latter would take it to triple digits.

To: Terry Maloney who wrote (80597)	5/15/2000 10:24:00 PM
From: Spekulatius	Read Replies (1) \| Respond to of 132070

I finally did the plunge and invested in VASO, the clinical data looks very good and the company clearly is very cheap with this huge business opportunity and a market cap of only 200M$. I think however, that market penetration may take a long time, unless they can make a deal with a big company in medical devices. I have been selling my insurance stocks after a nice rally and look for investment opportunities in the big cap world - I just cannot find any compelling buy right now.